131 related articles for article (PubMed ID: 37336836)
21. UBE2O Promotes Progression and Epithelial-Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma.
Chen X; Zhang S; Liu C; Li G; Lu S; Wang Y; Zhang X; Huang D; Qiu Y; Liu Y
Onco Targets Ther; 2020; 13():6191-6202. PubMed ID: 32636643
[TBL] [Abstract][Full Text] [Related]
22. Circ_0003747 promotes thyroid cancer progression by sponging miR-338-3p to upregulate PLCD3 expression.
Dou XL; Xia FD; Li XY
Epigenetics; 2023 Dec; 18(1):2210339. PubMed ID: 37166441
[TBL] [Abstract][Full Text] [Related]
23. Knockdown of lncRNA GHET1 inhibits osteosarcoma cells proliferation, invasion, migration and EMT in vitro and in vivo.
Yang W; Shan Z; Zhou X; Peng L; Zhi C; Chai J; Liu H; Yang J; Zhang Z
Cancer Biomark; 2018; 23(4):589-601. PubMed ID: 30475755
[TBL] [Abstract][Full Text] [Related]
24. Hsa_circ_0102272 serves as a prognostic biomarker and regulates proliferation, migration and apoptosis in thyroid cancer.
Liu J; Zheng X; Liu H
J Gene Med; 2020 Sep; 22(9):e3209. PubMed ID: 32367651
[TBL] [Abstract][Full Text] [Related]
25. A muscle-specific UBE2O/AMPKα2 axis promotes insulin resistance and metabolic syndrome in obesity.
Vila IK; Park MK; Setijono SR; Yao Y; Kim H; Badin PM; Choi S; Narkar V; Choi SW; Chung J; Moro C; Song SJ; Song MS
JCI Insight; 2019 Jul; 4(13):. PubMed ID: 31292296
[TBL] [Abstract][Full Text] [Related]
26. Novel role for p21-activated kinase 2 in thrombin-induced monocyte migration.
Gadepalli R; Kotla S; Heckle MR; Verma SK; Singh NK; Rao GN
J Biol Chem; 2013 Oct; 288(43):30815-31. PubMed ID: 24025335
[TBL] [Abstract][Full Text] [Related]
27. The rho-guanine nucleotide exchange factor domain of obscurin activates rhoA signaling in skeletal muscle.
Ford-Speelman DL; Roche JA; Bowman AL; Bloch RJ
Mol Biol Cell; 2009 Sep; 20(17):3905-17. PubMed ID: 19605563
[TBL] [Abstract][Full Text] [Related]
28. Transcription factors TP63 facilitates malignant progression of thyroid cancer by upregulating KRT17 expression and inducing epithelial-mesenchymal transition.
Meng F; Dai L
Growth Factors; 2023 Oct; 41(2):71-81. PubMed ID: 36919456
[TBL] [Abstract][Full Text] [Related]
29. STRA6 Promotes Thyroid Carcinoma Progression via Activation of the ILK/AKT/mTOR Axis in Cells and Female Nude Mice.
He W; Cheng Z; Huo Z; Lin B; Wang X; Sun Y; Yu S; Cao S; Xue J; Liu R; Lv W; Li Y; Hong S; Xiao H
Endocrinology; 2023 Jan; 164(3):. PubMed ID: 36592123
[TBL] [Abstract][Full Text] [Related]
30. IGF2BP2 knockdown suppresses thyroid cancer progression by reducing the expression of long non-coding RNA HAGLR.
Dong L; Geng Z; Liu Z; Tao M; Pan M; Lu X
Pathol Res Pract; 2021 Sep; 225():153550. PubMed ID: 34340128
[TBL] [Abstract][Full Text] [Related]
31. MiR-150 Inhibits Cell Growth In Vitro and In Vivo by Restraining the RAB11A/WNT/β-Catenin Pathway in Thyroid Cancer.
Bai D; Sun H; Wang X; Lou H; Zhang J; Wang X; Jiang L
Med Sci Monit; 2017 Oct; 23():4885-4894. PubMed ID: 29023429
[TBL] [Abstract][Full Text] [Related]
32. Phospholipase C Delta 3 inhibits apoptosis and promotes proliferation, migration, and invasion of thyroid cancer cells via Hippo pathway.
Lin L; Wen J; Lin B; Chen H; Bhandari A; Qi Y; Zheng D; Wang O
Acta Biochim Biophys Sin (Shanghai); 2021 Mar; 53(4):481-491. PubMed ID: 33674820
[TBL] [Abstract][Full Text] [Related]
33. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
[No Abstract] [Full Text] [Related]
34. LAGE3 promoted cell proliferation, migration, and invasion and inhibited cell apoptosis of hepatocellular carcinoma by facilitating the JNK and ERK signaling pathway.
Xing Y; Liu Y; Qi Z; Liu Z; Wang X; Zhang H
Cell Mol Biol Lett; 2021 Nov; 26(1):49. PubMed ID: 34837962
[TBL] [Abstract][Full Text] [Related]
35. Ubiquitin-conjugating enzyme E2T(UBE2T) promotes colorectal cancer progression by facilitating ubiquitination and degradation of p53.
Wu M; Li X; Huang W; Chen Y; Wang B; Liu X
Clin Res Hepatol Gastroenterol; 2021 Mar; 45(2):101493. PubMed ID: 32736946
[TBL] [Abstract][Full Text] [Related]
36. Endothelin A receptor drives invadopodia function and cell motility through the β-arrestin/PDZ-RhoGEF pathway in ovarian carcinoma.
Semprucci E; Tocci P; Cianfrocca R; Sestito R; Caprara V; Veglione M; Castro VD; Spadaro F; Ferrandina G; Bagnato A; Rosanò L
Oncogene; 2016 Jun; 35(26):3432-42. PubMed ID: 26522724
[TBL] [Abstract][Full Text] [Related]
37. Knockdown of long non‑coding RNA CCAT2 suppresses the progression of thyroid cancer by inhibiting the Wnt/β‑catenin pathway.
Xin S; Ye X
Int J Mol Med; 2020 Dec; 46(6):2047-2056. PubMed ID: 33125134
[TBL] [Abstract][Full Text] [Related]
38. Multiple anti-tumor effects of Reparixin on thyroid cancer.
Liotti F; De Pizzol M; Allegretti M; Prevete N; Melillo RM
Oncotarget; 2017 May; 8(22):35946-35961. PubMed ID: 28415590
[TBL] [Abstract][Full Text] [Related]
39. Long non-coding RNA TTN-AS1 facilitates tumorigenesis of papillary thyroid cancer through modulating the miR-153-3p/ZNRF2 axis.
Cui Z; Luo Z; Lin Z; Shi L; Hong Y; Yan C
J Gene Med; 2019 May; 21(5):e3083. PubMed ID: 30811764
[TBL] [Abstract][Full Text] [Related]
40. Carboxy terminus of HSP70-interacting protein (CHIP) attenuates the stemness of thyroid cancer cells through decreasing OCT4 protein stability.
Xu Y; Xu G; Dang H; Qu W; Chang D; He X; Li M; Wang Q
Environ Toxicol; 2021 Apr; 36(4):686-693. PubMed ID: 33270330
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
